Ryboquin's Grant

Ryboquin raised a round of funding on May 31, 2016. Investors include Scottish Enterprise.

Ryboquin, a drug development company, is focused on commercializing patented technologies in the area of human cancer medicine. The Company's aim is to grow shareholder value by developing new, effect…

Articles about Ryboquin's Grant: